Search results
Results from the WOW.Com Content Network
The pregnancy category of a medication is an assessment of the risk of fetal injury due to the pharmaceutical, if it is used as directed by the mother during pregnancy. It does not include any risks conferred by pharmaceutical agents or their metabolites in breast milk. Every drug has specific information listed in its product literature.
A cheat sheet (also cheatsheet) or crib sheet is a concise set of notes used for quick reference. Cheat sheets were historically used by students without an instructor or teacher's knowledge to cheat on a test or exam . [ 1 ]
Pregnancy category: C; Routes of administration: By mouth : ATC code: ... It is used in the treatment of dry mouth and Sjögren's syndrome. Medical uses
In the United States, empagliflozin is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure; [12] to reduce the risk of sustained decline in eGFR, end-stage kidney disease, cardiovascular death, and hospitalization in adults with chronic kidney disease at risk of progression; [12] to reduce the risk of cardiovascular death in ...
Reference notes. A reference card or reference sheet (or quick reference card) or crib sheet is a concise bundling of condensed notes about a specific topic, such as mathematical formulas [1] to calculate area/volume, or common syntactic rules and idioms of a particular computer platform, application program, or formal language.
Rifapentine has been assigned a pregnancy category C by the U.S. Food and Drug Administration (FDA). Rifapentine in pregnant women has not been studied, but animal reproduction studies have resulted in fetal harm and were teratogenic.
The actual definitions of the pregnancy categories are copied verbatim from the FDA regulations (which are in the public domain). Reference to some of the history: Sannerstedt R, Lundborg P, Danielsson BR, Kihlstrom I, Alvan G, Prame B, Ridley E. "Drugs during pregnancy: an issue of risk classification and information to prescribers."
This page was last edited on 4 September 2006, at 22:25 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.